<p style="text-align: center;"><img src="/ueditor/php/upload/image/20250823/1755951413885163.png" title="1755951413885163.png" alt="6.png"/></p><p style="text-align: justify;"><span style="font-family: arial, helvetica, sans-serif; font-size: 12px;">As part of SKF’s strategic focus on its core aerospace areas and exit of non-strategic business lines, the Group has signed an agreement to divest its precision elastomeric device (PED) operation in Elgin, Illinois, USA. Additionally, with the completed divestment of the Hanover operation, announced on 14 April 2025, SKF is expected to have successfully divested both non-core businesses identified in its aerospace strategic review. The Elgin PED operation represents 2024 annual sales of approximately SEK 260 million. It is divested to Carco PRP Group for a total estimated enterprise value of USD 70 million, corresponding to approximately SEK 700 million. “The Hanover and Elgin divestments are examples of our ongoing efforts to execute on our strategy and manage our portfolio to accelerate profitable growth. With this agreement, Elgin will be in a good position to develop its business even further, while we can focus on driving innovation and growth in our remaining core aerospace business”, says Thomas Fr?st, President, Independent and Emerging Business. SKF will maintain its focus on core aerospace segments related to aeroengine and aerostructure bearing offerings, which represent approximately SEK 6 billion in annual sales. These areas will be further strengthened through increased investments aimed at advancing digitalization, automation, and further modernizing the Group&#39;s factories. The Elgin PED divestment is expected to close during the fourth quarter of 2025, subject to authorities’approval.</span></p>